home > epc

European Pharmaceutical Contractor


European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.


For further information please contact:

Jonathan Smith

Charlie Burgon

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

View the digital version of EPC


Featured in this issue
In Conclusion
In Conclusion

The Path to Prevention

Can finding a cure have the opposite of the desired effect? Graham Hughes explores the landscape of contagious and deadly diseases.
IT Solutions
Information Management

Single Source

Storing information across multiple systems often results in time-consuming and error-prone clinical processes. Devising a single source of content adds visibility and control, which translates into faster therapy development, reasons Rik van Mol of Veeva Systems.
  Regional Focus
Clinical Research: Turkey

Land of Opportunity

At the centre of an emerging region, Turkey boasts a supportive regulatory framework, a large number of sites and diverse patients, and a competive cost structure. Ömer Sadun Okyaltırık and Yamin Khan of Pharm-Olam report.

Edited by
Dr Graham Hughes,
Consultant in
Published quarterly in
March, June,
September and December
Banner of Medical Research Network (MRN) Limited on Samedan
Banner of ESMO.EPC on Samedan
Banner of Inform.EPC on Samedan
Industry Events

Advances in Cell Based Assays

10-11 November 2015, Holiday Inn Kensington Forum

SMi Group are thrilled to present the 8th annual conference in the industry leading series, Advances in Cell Based Assays, taking place on 10th & 11th November 2015 in Central London, UK.
More info >>

News and Press Releases

Industry titans Biocon, PBOA, PCI Clinical Services and Pharmatech Associates join CPhI annual report for 2015

CPhI Worldwide, organised by UBM EMEA, announces the addition of four new high profile experts to the CPhI annual report, taking the total up to a record breaking 14 panellists for 2015.
More info >>

Banner of Drug Delivery Congress on Samedan
air transport logo


White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement